Invention Grant
- Patent Title: Inhalable medicament comprising tiotropium
-
Application No.: US14367031Application Date: 2012-12-06
-
Publication No.: US09655969B2Publication Date: 2017-05-23
- Inventor: Xian-Ming Zeng
- Applicant: TEVA Branded Pharmaceutical Products R&D, Inc.
- Applicant Address: US PA Horsham
- Assignee: Teva Branded Pharmaceutical Products R&D, Inc.
- Current Assignee: Teva Branded Pharmaceutical Products R&D, Inc.
- Current Assignee Address: US PA Horsham
- Agency: Baker Hostetler LLP
- Priority: GB1200525.2 20120113
- International Application: PCT/EP2012/074690 WO 20121206
- International Announcement: WO2013/092237 WO 20130627
- Main IPC: A61K47/12
- IPC: A61K47/12 ; A61K9/00 ; A61K31/439 ; A61K31/46 ; A61K47/10 ; A61M15/00
Abstract:
This invention relates to a solution formulation containing a tiotropium salt, 12-20% ethanol, 0.1-1.5% of water, 0.05-0.10% citric acid (or other organic acid) and an HFA propellant, wherein the percentages are percentages by weight based on the total weight of the formulation. The invention also provides a pMDI comprising a canister containing the formulation.
Public/Granted literature
- US20140348758A1 INHALABLE MEDICAMENT COMPRISING TIOTROPIUM Public/Granted day:2014-11-27
Information query
